Post-treatment recurrence risk low for multidrug-resistant TB
Jessica Nye
Oct. 26, 2023, 8:07 p.m.
There was a low risk for post-treatment recurrence among patients who received treatment for multidrug- or rifampicin-resistant tuberculosis infection.